1. In this cohort study, the quadrivalent human papillomavirus (HPV) vaccine provides strong, long-lasting protection against invasive cervical cancer, with ...
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study 1. In this cohort study, ...
1. In this individual-based modeling study, fewer cervical cancer screens for HPV-vaccinated women were the most cost-effective strategy. 2. Fewer ...
1. Punjab launched India’s first large-scale AI screening program for cancer and eye disease. 2. The initiative aims to perform ...
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
Lilly unveils TuneLab AI platform for biotechs On September 9, 2025, Eli Lilly officially unveiled TuneLab, a federated AI platform ...
1. Cadonilimab plus chemotherapy significantly improved progression-free survival in patients with persistent, recurrent, or metastatic cervical cancer. 2. Common grade ...
1. In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when ...
1. 5-year progression-free survival was increased in the induction chemotherapy group compared to standard chemoradiotherapy. 2. Patients in the induction ...
1. 36-month overall survival was significantly greater in the pembrolizumab-chemoradiotherapy group compared to placebo-chemoradiotherapy. 2. Grade 3 or higher adverse ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
